Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001895222 | SCV002153081 | likely benign | Multiple sulfatase deficiency | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001895222 | SCV002775341 | uncertain significance | Multiple sulfatase deficiency | 2022-02-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002552328 | SCV003751800 | uncertain significance | Inborn genetic diseases | 2021-12-20 | criteria provided, single submitter | clinical testing | The c.233G>A (p.G78D) alteration is located in exon 1 (coding exon 1) of the SUMF1 gene. This alteration results from a G to A substitution at nucleotide position 233, causing the glycine (G) at amino acid position 78 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |